Lifesci Capital Has Negative Outlook of AVDL FY2024 Earnings
Avadel Pharmaceuticals plc (NASDAQ:AVDL – Free Report) – Investment analysts at Lifesci Capital decreased their FY2024 earnings per share (EPS) estimates for Avadel Pharmaceuticals in a research report issued on Thursday, January 9th. Lifesci Capital analyst M. Belghiti now anticipates that the company will post earnings per share of ($0.46) for the year, down from […]
More Stories
S.E.E.D. Planning Group LLC Has $5.72 Million Stock Holdings in Agilent Technologies, Inc. (NYSE:A)
S.E.E.D. Planning Group LLC increased its position in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 12.7% during...
S.E.E.D. Planning Group LLC Increases Stock Position in CoStar Group, Inc. (NASDAQ:CSGP)
S.E.E.D. Planning Group LLC increased its holdings in CoStar Group, Inc. (NASDAQ:CSGP – Free Report) by 7.1% in the fourth...
Radnor Capital Management LLC Has $1.22 Million Stake in Acuity Brands, Inc. (NYSE:AYI)
Radnor Capital Management LLC reduced its position in Acuity Brands, Inc. (NYSE:AYI – Free Report) by 6.7% during the fourth...
Rockwell Automation, Inc. (NYSE:ROK) Shares Bought by M. Kraus & Co
M. Kraus & Co lifted its stake in shares of Rockwell Automation, Inc. (NYSE:ROK – Free Report) by 0.5% in...
Wright Investors Service Inc. Has $1.90 Million Stake in Eli Lilly and Company (NYSE:LLY)
Wright Investors Service Inc. trimmed its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 33.3% in the...
Exeter Financial LLC Increases Stake in Chevron Co. (NYSE:CVX)
Exeter Financial LLC boosted its holdings in shares of Chevron Co. (NYSE:CVX – Free Report) by 2.5% in the fourth...